Raffaella CasolinoFollowUniversity of Glasgow1 paperORCID 0000-0002-4151-9736 ↗OpenAlex ↗PapersThe Lancet OncologyReview·26 SepBalancing benefits, costs, and harms: policy implications of expanding cancer susceptibility testing from genetics clinics to the general population
The Lancet OncologyReview·26 SepBalancing benefits, costs, and harms: policy implications of expanding cancer susceptibility testing from genetics clinics to the general population